Artemii is a postdoc at O’BRAIN lab. He is interested in personalised obesity treatments and diagnostics, as well as the neural basis of the eating behavior in health and pathology.Artemii obtained his PhD in biology of obesity from Lille University (2019). For his thesis project he studied immunometabolic and molecular mechanisms of adipose tissue homeostasis using functional genomics and preclinical animal models of diet induced obesity. He was also trained in clinical psychology with the focus on eating disorders.Artemii joined O’BRAIN lab in January 2023, and is currently working on the NeuroPOD project (Neurocognitive profiling for Personalised Obesity Diagnostics) aimed at development of AI-aided tailored obesity disgnostics based on psychological and neural activity data. He is also involved in MEGAPET study designed to decipher how molecular disturbances in the brain dopamine system are associated with obesity onset and progression.
|Dec. 2022—||Postdoc at O’BRAIN Lab
University of Helsinki, Faculty of Medicine, Department of Psychology, Helsinki, Finland
|Jan. 2021–June 2022||Clinical practice under supervision (Internship)
Online Counseling in Eating Disorders
|Sep. 2020–June 2021||Postgraduate degree in Clinical Psychology,
Moscow Institute of Psychoanalysis
|Dec. 2019–May 2021||Postdoc at Inserm UMR1011
Pasteur Institute of Lille, Lille, France
|Oct. 2016–Dec. 2019||PhD in Biology,University of Lille|
|Sep. 2014–June 2016||MSc in Biology — Biochemistry and Molecular Biology,
Saint-Petersburg State University
|Sep. 2010–July 2014||BSc in Biology — Physiology and Biomedicine,
Saint-Petersburg State University
Mogilenko D.A*, Nikitin A*, Hosoya K, Fleury S, Quemener S, Pic S, Pineau L, Molendi- Coste O, Pipoli da Fonseca J, Derudas B, Eeckhoute J, Staels B, Dombrowicz D. The regulatory T cell-expressed nuclear receptor RORa controls protective and pathogenic type 2 immunity (in preparation)
Tanyanskiy, D.A., Trulioff, A.S., Ageeva, E.V., Nikitin, A.A., Shavva, V.S., Orlov, S.V. The Influence of Adiponectin on Production of Apolipoproteins A‑1 and E by Human
Macrophages. Mol Biol 55, 637–643 (2021).
Shavva, V.S., Mogilenko, D.A., Bogomolova, A.M., Nikitin, A.A., Dizhe, E.B., Efremov, A.M., Oleinikova, G.N., Perevozchikov, A.P., and Orlov, S.V. (2016). PPARγ Represses Apolipoprotein A‑I Gene but Impedes TNFα-Mediated ApoA‑I Downregulation in HepG2 Cells. J. Cell. Biochem.
Haas, J.T., Vonghia, L., Mogilenko, D.A. et al. Transcriptional network analysis implicates altered hepatic immune function in NASH development and resolution. Nat Metab 1, 604–614 (2019). https://doi-org.proxy.insermbiblio.inist.fr/10.1038/s42255-019‑0076‑1
Mogilenko DA, Haas JT, L’homme L, Fleury S, Quemener S, Levavasseur M, Becquart C, Wartelle J, Bogomolova A, Pineau L, Molendi-Coste O, Lancel S, Dehondt H, Gheeraert C, Melchior A, Dewas C, Nikitin A, Pic S, Rabhi N, Annicotte JS, Oyadomari S, Velasco- Hernandez T, Cammenga J, Foretz M, Viollet B, Vukovic M, Villacreces A, Kranc K, Carmeliet P, Marot G, Boulter A, Tavernier S, Berod L, Longhi MP, Paget C, Janssens S, Staumont-Sallé D, Aksoy E, Staels B, Dombrowicz D. Metabolic and Innate Immune Cues Merge into a Specific Inflammatory Response via the UPR. Cell. 2019 May 16;177(5):1201- 1216.e19. doi: 10.1016/j.cell.2019.03.018. Epub 2019 Apr 25. Cell. 2019 Jun 27;178(1):263. PMID: 31031005